CONTRIBUTION OF THE C-8 SUBSTITUENT OF DU-6859A, A NEW POTENT FLUOROQUINOLONE, TO ITS ACTIVITY AGAINST DNA GYRASE MUTANTS OF PSEUDOMONAS-AERUGINOSA

被引:43
作者
KITAMURA, A
HOSHINO, K
KIMURA, Y
HAYAKAWA, I
SATO, K
机构
[1] Exploratory Research Laboratories I, Daiichi Pharmaceutical Co., Ltd., Edogawa, Tokyo 134, 16-13
关键词
D O I
10.1128/AAC.39.7.1467
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inhibitory effects of five quinolones against DNA gyrases purified from four quinolone-resistant clinical isolates of Pseudomonas aeruginosa and the quinolone-susceptible strain PAO1 were examined. All of the quinolone-resistant strains tested were found to be DNA gyrase mutants. The 50% inhibitory concentrations (IC(50)s) of the quinolones for these DNA gyrases roughly correlated with their MICs. Interestingly, gyrase inhibition by DU-6859a was found to be significantly less affected by these mutations than inhibition by other currently available quinolones. To assess the enhanced activity shown by DU-6859a, the effects of quinolones with altered substituents at the N-1, C-7, and C-8 positions of the quinolone ring of DU-6859a were tested. Measurement of MICs for four DNA gyrase mutants and IC(50)s for their purified DNA gyrases showed that removal of the C-8 chlorine of DU-6859a significantly increased MICs and IC(50)s for DNA gyrase mutants. However, no deleterious effects were observed when either the fluorine on the cyclopropyl substituent at the N-1 position or the cyclopropyl ring at the C-7 substituent was removed. Moreover, removal of the C-8 chlorine also increased the MIC for 19 of 20 quinolone-resistant clinical isolates. Our results led to the conclusion that DU-6859a is much more active against quinolone-resistant clinical isolates of P. aeruginosa than other currently available quinolones, probably because of its strong inhibitory effects against mutant quinolone-resistant DNA gyrases, and that the C-8 chlorine is necessary for these potent effects.
引用
收藏
页码:1467 / 1471
页数:5
相关论文
共 31 条
[1]   CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES [J].
FERRERO, L ;
CAMERON, B ;
MANSE, B ;
LAGNEAUX, D ;
CROUZET, J ;
FAMECHON, A ;
BLANCHE, F .
MOLECULAR MICROBIOLOGY, 1994, 13 (04) :641-653
[2]   ACTIVITY OF NEW QUINOLONES AGAINST CIPROFLOXACIN-RESISTANT STAPHYLOCOCCI [J].
FORSTALL, GJ ;
KNAPP, CC ;
WASHINGTON, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (08) :1679-1681
[3]   CIPROFLOXACIN-INDUCED, LOW-LEVEL RESISTANCE TO STRUCTURALLY UNRELATED ANTIBIOTICS IN PSEUDOMONAS-AERUGINOSA AND METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
FUNGTOMC, J ;
KOLEK, B ;
BONNER, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1289-1296
[4]   DNA GYRASE - ENZYME THAT INTRODUCES SUPERHELICAL TURNS INTO DNA [J].
GELLERT, M ;
MIZUUCHI, K ;
ODEA, MH ;
NASH, HA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (11) :3872-3876
[5]   USE OF A BROAD-HOST-RANGE GYRA PLASMID FOR GENETIC-CHARACTERIZATION OF FLUOROQUINOLONE-RESISTANT GRAM-NEGATIVE BACTERIA [J].
HEISIG, P ;
WIEDEMANN, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2031-2036
[6]   MUTATIONS PRODUCING RESISTANCE TO NORFLOXACIN IN PSEUDOMONAS-AERUGINOSA [J].
HIRAI, K ;
SUZUE, S ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :582-586
[7]  
HOHMURA M, 1991, 17TH INT C CHEM INT
[8]   COMPARISON OF INHIBITION OF ESCHERICHIA-COLI TOPOISOMERASE-IV BY QUINOLONES WITH DNA GYRASE INHIBITION [J].
HOSHINO, K ;
KITAMURA, A ;
MORRISSEY, I ;
SATO, K ;
KATO, J ;
IKEDA, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) :2623-2627
[9]  
HOSHINO K, 1993, 33 INT C ANT AG CHEM, P298
[10]   SOME PROPERTIES OF SUBUNITS OF DNA GYRASE FROM PSEUDOMONAS-AERUGINOSA PA01 AND ITS NALIDIXIC ACID-RESISTANT MUTANT [J].
INOUE, Y ;
SATO, K ;
FUJII, T ;
HIRAI, K ;
INOUE, M ;
IYOBE, S ;
MITSUHASHI, S .
JOURNAL OF BACTERIOLOGY, 1987, 169 (05) :2322-2325